Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 30 Carcinoma, Hepatocellular 13 Rectal Neoplasms 5 Sarcoma, Ewing 4 Osteosarcoma 4 Gastrointestinal Stromal Tumors 4 Colonic Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Glioblastoma 3 Sarcoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Bone Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Piebaldism 1 Patient Compliance 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 lutetium Lu 177 dotatate 6 Specimen Handling 5 Bevacizumab 4 gallium Ga 68 dotatate 3 abemaciclib 3 Radiosurgery 3 Proton Therapy 3 Nivolumab 3 pembrolizumab 2 Surveys and Questionnaires 2 Sunitinib 2 Protons 2 Observation 2 ONC206 2 Ipilimumab 2 Hydroxyurea 2 Ga(III)-DOTATOC 2 Everolimus 2 Elasticity Imaging Techniques 2 CTLA-4 Antigen 2 ribociclib 1 regorafenib 1 olaparib 1 neratinib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 capivasertib 1 cabozantinib 1 brigatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × regorafenib × 1 year × Clear all

NCT06275919 2026-05-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡